Skip to content

Clinical trials

Phase 1/2 Pancreatic Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Phase: Phase 1/2 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20112
20162
20171
20213
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting3
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
Ability Pharmaceuticals SL1
Alligator Bioscience AB1
Bayer1
Bristol-Myers Squibb1
Centocor, Inc.1
EMD Serono Research & Development Institute, Inc.1
Incyte Corporation1
Institut du Cancer de Montpellier - Val d'Aurelle1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms13
Carcinoma, Non-Small-Cell Lung5
Colorectal Neoplasms4
Ovarian Neoplasms4
Endometrial Neoplasms3
Neoplasm Metastasis3
Lung Neoplasms2
Neoplasms2
Stomach Neoplasms2
Triple Negative Breast Neoplasms2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.